Azelis announces its appointment as exclusive distributor by Tagra Biotechnologies, to offer their range of RND® microencapsulated actives and pigments in India, Australia and New Zealand for all personal care applications. This new partnership builds on agreements between the two companies in Europe and Canada.
[wp_ad_camp_4]Lito Ickowicz, Director Business Development, Tagra Biotechnologies states: “Tagra looks forward to extending our successful partnership with Azelis into India, Australia and New Zealand. Together we aim to offer customers high quality technical service and innovative application insights. Azelis has proven to be a trusted and dynamic partner. We work well together and the decision to extend our partnership was a natural one.”
Laurent Nataf, CEO & President Asia Pacific adds: “We are delighted to expand our partnership with Tagra into the Asia Pacific region. Tagra’s highly innovative ingredients are a welcome addition to our portfolio, fitting well with our strategy to focus on speciailties and create value for our Asia Pacific customers.”
Tagra Biotechnologies is a hub for specialty cosmetic ingredients, combining development and manufacturing of innovative encapsulated actives and pigments. They are world leader in Release on Demand™ (RND™) Microencapsulation Technology, a patented method providing stability, efficiency and controlled/immediate release for non-water soluble ingredients.
This technology enables the production of encapsulated ingredients including actives, vitamins, essential oils, flavonoids, silicons, pigments and sunscreens, all conforming to worldwide cosmetic regulations and suitable for a wide range of formulations.
The agreement comes into force from September 2016.